Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Insiders Favor These 3 Prominent Growth Stocks

In This Article:

As global markets navigate a choppy start to the year, with U.S. equities facing pressure from inflation concerns and political uncertainties, investors are keenly observing how insider ownership might signal confidence in potential growth opportunities. In this environment, companies where insiders hold significant stakes can often be seen as promising investments, as their leadership has a vested interest in the long-term success of the business amidst economic fluctuations.

Top 10 Growth Companies With High Insider Ownership

Name

Insider Ownership

Earnings Growth

Duc Giang Chemicals Group (HOSE:DGC)

31.4%

23.8%

Archean Chemical Industries (NSEI:ACI)

22.9%

41.2%

Kirloskar Pneumatic (BSE:505283)

30.3%

26.3%

Clinuvel Pharmaceuticals (ASX:CUV)

10.4%

25.4%

People & Technology (KOSDAQ:A137400)

16.4%

37.3%

Medley (TSE:4480)

34%

27.2%

Brightstar Resources (ASX:BTR)

16.2%

84.3%

Plenti Group (ASX:PLT)

12.8%

120.1%

Fulin Precision (SZSE:300432)

13.6%

66.7%

Findi (ASX:FND)

34.8%

112.9%

Click here to see the full list of 1455 stocks from our Fast Growing Companies With High Insider Ownership screener.

We're going to check out a few of the best picks from our screener tool.

HYBE

Simply Wall St Growth Rating: ★★★★☆☆

Overview: HYBE Co., Ltd. operates in music production, publishing, and artist development and management, with a market cap of ₩9.27 trillion.

Operations: The company's revenue is derived from three main segments: Label (₩1.29 trillion), Platform (₩337.18 billion), and Solution (₩1.21 trillion).

Insider Ownership: 32.5%

Revenue Growth Forecast: 16.7% p.a.

HYBE is navigating leadership changes with Shin Seon-jeong as Big Hit Music's new CEO, reinforcing Bang Si-hyuk's authority. The company aims to enhance global competitiveness amid slower revenue growth forecasts of 16.7% annually, outpacing the KR market. Despite a challenging third quarter with significant declines in net income and earnings per share, HYBE trades at 15.8% below its estimated fair value and is expected to achieve above-average market profit growth over the next three years.

KOSE:A352820 Ownership Breakdown as at Jan 2025
KOSE:A352820 Ownership Breakdown as at Jan 2025

Surgical Science Sweden

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training globally, with a market cap of SEK8.93 billion.

Operations: The company's revenue is divided into two main segments: Industry/OEM, generating SEK419.66 million, and Educational Products, contributing SEK440.17 million.

Waiting for permission
Allow microphone access to enable voice search

Try again.